Biocon Says Won’t Play The Bloodbath Game In  Indian Market For Now
Kiran Mazumdar-Shaw, managing director and co-founder of Biocon Ltd., gestures during an interview in Bengaluru, India. (Photographer: Samyukta Lakshmi/Bloomberg)

Biocon Says Won’t Play The Bloodbath Game In Indian Market For Now

Biocon Ltd.—India's second-best performing pharmaceutical stock this year—will continue to focus on Europe and the U.S. in 2019.That's according to Chairperson and Managing Director Kiran Mazumdar-...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.